Document is current
Any future updates will be listed below
-
Authors
Rigiroli, Francesca https://orcid.org/0000-0002-5262-5585
Hoye, Jocelyn
Lerebours, Reginald
Lyu, Peijie
Lafata, Kyle J.
Zhang, Anru R.
Erkanli, Alaattin
Mettu, Niharika B.
Morgan, Desiree E.
Samei, Ehsan
Marin, Daniele
- License Information
-
More Information
Article History
Received: 7 September 2022
Revised: 23 November 2022
Accepted: 29 January 2023
First Online: 10 March 2023
Declarations
:
: The scientific guarantor of this publication is Francesca Rigiroli.
: Francesca Rigiroli MD: Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: received funding as research fellowship from Bracco Diagnostics Inc.Reginald Lerebours MA: Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: received support from the National Center for Advance Translational Sciences (NCATS) of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research (Grant Number UL1TR002553).Peijie Lyu MD: Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: received funding as research fellowship from GE Healthcare.Ehsan Samei PhD: Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: is a consultant for Imalogix; has given expert testimony for Rubin Anders; institution has grants or grants pending with Siemens Healthineers and Bracco. Other relationships: institution receives royalties for intellectual property from GE Healthcare, Imalogix, 12Sigma, and SunNuclear.Daniele Marin MD: Activities related to the present article: institution received research support from Siemens Healthineers (provision of software tools) without the payment of any money. Activities not related to the present article: has received speakers fees from Siemens Healthineers for clinical lectures.
: Three authors have significant statistical expertise.
: Written informed consent was waived by the institutional review board.
: Institutional review board approval was obtained.
: Some study subjects (<i>n</i> = 50) have been previously reported in “CT Radiomic Features of Superior Mesenteric Artery Involvement in Pancreatic Ductal Adenocarcinoma: A Pilot Study”.Francesca Rigiroli, Jocelyn Hoye, Reginald Lerebours, Kyle J. Lafata, Cai Li, Mathias Meyer, Peijie Lyu, Yuqin Ding, Fides R. Schwartz, Niharika B. Mettu, Sabino Zani Jr, Sheng Luo, Desiree E. Morgan, Ehsan Samei, and Daniele Marin. <i>Radiology</i> 2021 301:3, 610–622.
: • retrospective• diagnostic or prognostic study• multicenter study
